MedTrace Logo

Reduction of Inappropriate Shocks of Implantable Cardioverter Defibrillators (ICDs) With Enhanced SVT Discriminators

NCT01963286 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 735

Last updated 2019-02-04

No results posted yet for this study

Summary

The purpose of this clinical investigation is the continued assessment of the decision accuracy of St. Jude Medical (SJM) ICD with enhanced SVT discriminators in the treatment of subjects with primary and secondary prevention of sudden cardiac death.

Conditions

  • Tachycardia

Interventions

DEVICE

ICD with enhanced SVT discriminators

ICD will be programmed to uniform device settings with enhanced SVT discrimintators enabled.

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Johann C Geller, Prof. Dr. · Zentralklinik Bad Berka

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • Estonia
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01963286 on ClinicalTrials.gov